AI is rapidly shifting from experimentation to real‑world execution across the entire drug development lifecycle. In this Outsourced Pharma Capabilities Update webinar, you’ll learn how artificial intelligence is already delivering measurable value today—and how Lonza partners with customers to shorten development cycle times, improve quality, and de‑risk scale‑up.
This session will focus on how Lonza’s AI‑enabled solid‑form screening toolkit is transforming cocrystal development. By applying advanced machine‑learning models, Lonza scientists can accurately predict the most stable, developable, and manufacturable cocrystal forms early in the process. These AI‑driven predictions reduce experimental workload, accelerate form selection, and lower overall development risk.
View our on-demand webinar to understand how AI‑guided insights streamline laboratory workflows, improve decision‑making, and enable faster identification of optimal solid‑form candidates—ultimately helping drug developers bring high‑quality products to market more efficiently.
